Suzanne M. Sensabaugh is President of HartmannWillner LLC, where she provides professional advice to clients. She has over 20 years of experience in regulatory affairs, drug development, and FDA compliance with a focus on biologics, biosimilars, and biologics/device combination products. Her experience was gained in the FDA, pharmaceutical industry, and consulting environments. She has 10 years of experience at the FDA/CBER as a researcher, product reviewer, and inspector for biologics. Her industry career began at Genzyme Corporation. Suzanne has held numerous senior and executive positions in industry at Teva Pharmaceutical Industries, MDS Pharma Services, and Panacea Pharmaceuticals. She received her MBA from Duke University, MS from Johns Hopkins University, and BS from the University of Maryland. Suzanne is Adjunct Faculty at Johns Hopkins University.